Consultation on new products for specialised services
NHS England has launched a public consultation on a proposed number of new products for specialised services, including fampridine for multiple sclerosis in adult patients and ziconotide for chronic refractory cancer pain. The consultation is available from the NHS England website until 27 March 2016.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20200794
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com